HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamas Bartfai Selected Research

7- ((9- fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino- 4- methylcoumarin

6/2005Galnon--a low-molecular weight ligand of the galanin receptors.
2/2004Regulation of feeding by galnon.
12/2003Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.
5/2002Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamas Bartfai Research Topics

Disease

12Seizures (Absence Seizure)
10/2011 - 04/2002
6Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2005
6Pain (Aches)
11/2012 - 07/2004
6Body Weight (Weight, Body)
10/2012 - 02/2007
6Obesity
12/2010 - 02/2007
5Inflammation (Inflammations)
12/2012 - 06/2003
5Fever (Fevers)
03/2010 - 03/2002
4Epilepsy (Aura)
10/2011 - 07/2004
4Infections
10/2011 - 06/2003
4Status Epilepticus (Complex Partial Status Epilepticus)
08/2010 - 05/2002
3Insulin Resistance
07/2012 - 11/2008
3Hyperthermia
04/2011 - 01/2010
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2008 - 01/2005
2Neuroinflammatory Diseases
01/2020 - 02/2008
2Dementia (Dementias)
01/2017 - 07/2013
2Neuralgia (Stump Neuralgia)
11/2012 - 12/2003
2Substance-Related Disorders (Drug Abuse)
11/2012 - 08/2003
2Type 2 Diabetes Mellitus (MODY)
04/2011 - 11/2008
2Depressive Disorder (Melancholia)
08/2008 - 03/2005
2Traumatic Brain Injuries (Traumatic Brain Injury)
10/2007 - 08/2002
2Febrile Seizures (Febrile Seizure)
10/2007 - 01/2005
2Hyperalgesia
02/2006 - 12/2003
2Nervous System Diseases (Neurological Disorders)
01/2005 - 08/2003
2Brain Injuries (Brain Injury)
08/2002 - 08/2002
1Amyloidosis
01/2020
1Hypothermia
01/2017
1Central Nervous System Diseases (CNS Diseases)
01/2017
1Neoplasms (Cancer)
03/2016
1Prostatic Neoplasms (Prostate Cancer)
03/2016
1Migraine Disorders (Migraine)
11/2012
1Peripheral Nervous System Diseases (PNS Diseases)
11/2012
1Sleep Wake Disorders
11/2012
1Schizophrenia (Dementia Praecox)
11/2012
1Alcoholism (Alcohol Abuse)
07/2012
1Virus Diseases (Viral Diseases)
10/2011
1Hypertrophy
12/2010
1Weight Loss (Weight Reduction)
12/2010

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
01/2020 - 08/2003
9GalaninIBA
07/2012 - 04/2002
7CytokinesIBA
12/2012 - 08/2002
7NeuropeptidesIBA
11/2012 - 08/2003
7Galanin Receptors (Galanin Receptor)IBA
08/2010 - 05/2002
6Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2011 - 08/2002
5LigandsIBA
11/2012 - 01/2005
5Insulin (Novolin)FDA Link
10/2012 - 02/2007
5Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2009 - 08/2002
5Proteins (Proteins, Gene)FDA Link
03/2009 - 05/2004
4Interleukin-1 (Interleukin 1)IBA
11/2008 - 08/2002
4Antidepressive Agents (Antidepressants)IBA
08/2008 - 07/2004
47- ((9- fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino- 4- methylcoumarinIBA
06/2005 - 05/2002
3Anticonvulsants (Antiepileptic Drugs)IBA
10/2011 - 10/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
10/2011 - 06/2003
3Dinoprostone (PGE2)FDA Link
03/2011 - 02/2006
3Interleukin-18 (Interleukin 18)IBA
11/2008 - 03/2002
3Messenger RNA (mRNA)IBA
06/2005 - 01/2005
2Insulin-Like PeptidesIBA
01/2017 - 04/2011
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2016 - 07/2012
2Neuropeptide Receptors (Neuropeptide Receptor)IBA
11/2012 - 08/2003
2LeptinIBA
10/2012 - 02/2007
2AdiponectinIBA
10/2012 - 11/2011
2Insulin-Like Growth Factor I (IGF-1)IBA
10/2012 - 04/2011
2Glucose (Dextrose)FDA LinkGeneric
07/2012 - 12/2010
2Indomethacin (Indometacin)FDA LinkGeneric
03/2011 - 02/2006
2ProstaglandinsIBA
03/2011 - 02/2006
2AntipyreticsIBA
03/2010 - 10/2007
2Protein Isoforms (Isoforms)IBA
01/2010 - 08/2002
2CeramidesIBA
12/2008 - 02/2006
2Interleukin-1beta (Interleukin 1 beta)IBA
12/2008 - 01/2005
2Kainic Acid (Kainate)IBA
12/2008 - 02/2008
2Peptides (Polypeptides)IBA
02/2008 - 03/2005
2Neuroprotective AgentsIBA
07/2004 - 08/2002
2Pentylenetetrazole (Metrazol)IBA
02/2004 - 05/2002
1Biological ProductsIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2017
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2016
1Small Interfering RNA (siRNA)IBA
03/2016
1Biomarkers (Surrogate Marker)IBA
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2012
1Vasopressins (Vasopressin)IBA
11/2012
1Endothelin Receptor AntagonistsIBA
11/2012
1Neurokinin-1 Receptor AntagonistsIBA
11/2012
1NeurotensinIBA
11/2012
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2012
1AngiotensinsIBA
11/2012
1OrexinsIBA
11/2012
1InterleukinsIBA
10/2011
1Insulin ReceptorIBA
04/2011
1Fatty Acids (Saturated Fatty Acids)IBA
04/2011
1Tyrosine Kinase InhibitorsIBA
04/2011
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2011
1PyrogensIBA
03/2011
1LipidsIBA
12/2010
1Glucagon-Like Peptide-1 ReceptorIBA
12/2010
1(9H- fluoren- 9- yl)methyl(1- ((6- (tert- butoxycarbonyl)amino- 1- ((4- methyl- 2- oxo- 1,2- dihydroquinolin- 7- yl)amino)- 1- oxohexan- 2- yl)amino)- 3- cyclohexyl- 1- oxopropan- 2- yl)carbamateIBA
08/2010
1Pilocarpine (Ocusert)FDA LinkGeneric
08/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2010
1Oxygen (Dioxygen)IBA
01/2010
1Leptin ReceptorsIBA
01/2010

Therapy/Procedure

2Therapeutics
01/2011 - 09/2010
1Glycemic Control
12/2010